Results 221 to 230 of about 300,238 (255)

HEPARIN, LOW MOLECULAR WEIGHT HEPARIN, AND HEPARIN ANALOGUES

British Journal of Haematology, 1984
openaire   +2 more sources

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

New England Journal of Medicine, 2021
Patrick R Lawler, Ewan C Goligher, Jeffrey S Berger   +2 more
exaly  

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

New England Journal of Medicine, 2021
Ewan C Goligher, Charlotte A Bradbury, Bryan J Mcverry   +2 more
exaly  

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Lancet, The, 2022
exaly  

Heparin

1980
openaire   +2 more sources

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Lancet, The, 2022
exaly  

Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial

Lancet, The, 2023
exaly  

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

Lancet, The, 2018
Marco Valgimigli, Sergio Leonardi, Matteo Tebaldi   +2 more
exaly  

Heparin

2015
openaire   +2 more sources

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison

Lancet, The, 2007
Christopher F Bladin
exaly